Share on StockTwits

Shares of CEL-SCI Corp. (NYSE:CVM) were the target of a significant decrease in short interest in the month of August. As of August 15th, there was short interest totalling 3,310,388 shares, a decrease of 7.9% from the July 31st total of 3,592,452 shares, reports. Approximately 6.5% of the company’s shares are short sold. Based on an average trading volume of 337,914 shares, the days-to-cover ratio is currently 9.8 days.

CEL-SCI Corp. (NYSE:CVM) opened at 1.08 on Wednesday. CEL-SCI Corp. has a one year low of $0.53 and a one year high of $2.10. The stock has a 50-day moving average of $1.13 and a 200-day moving average of $1.22. The company’s market cap is $86.0 million.

CEL-SCI Corp. (NYSE:CVM) last released its earnings data on Friday, August 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.11) by $0.07. Analysts expect that CEL-SCI Corp. will post $-0.42 EPS for the current fiscal year.

CEL-SCI Corporation (NYSE:CVM) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.

Receive News & Ratings for CEL-SCI Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CEL-SCI Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.